These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35330963)

  • 1. CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells.
    Angelopoulou A; Papaspyropoulos A; Papantonis A; Gorgoulis VG
    STAR Protoc; 2022 Jun; 3(2):101257. PubMed ID: 35330963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.
    Caillaud A; Lévêque A; Thédrez A; Girardeau A; Canac R; Bray L; Baudic M; Barc J; Gaborit N; Lamirault G; Gardie B; Idriss S; Rimbert A; Le May C; Cariou B; Si-Tayeb K
    STAR Protoc; 2022 Dec; 3(4):101680. PubMed ID: 36115027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in
    Picchi-Constante GFA; Hiraiwa PM; Marek M; Rogerio VZ; Guerra-Slompo EP; Romier C; Zanchin NIT
    STAR Protoc; 2022 Jun; 3(2):101324. PubMed ID: 35496799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
    Novarina D; Koutsoumpa A; Milias-Argeitis A
    STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing in
    Sinha T; Yazdani SS
    STAR Protoc; 2022 Sep; 3(3):101629. PubMed ID: 36042883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Chromosomal Rearrangements via Combinatorial Use of CRISPR/Cas9 and Cre/
    Chen X; Liao S; Huang X; Xu T; Feng X; Guang S
    G3 (Bethesda); 2018 Jul; 8(8):2697-2707. PubMed ID: 29950430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in
    Wang Y; Wang Z; Ji Q
    STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing the Native Type I-F CRISPR-Cas System in
    Xu Z; Li Y; Yan A
    STAR Protoc; 2020 Jun; 1(1):100039. PubMed ID: 33111087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
    Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
    STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 strategies to insert MS2 stem-loops into endogenous loci in
    Hoppe C; Ashe HL
    STAR Protoc; 2021 Mar; 2(1):100380. PubMed ID: 33786461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of mouse hippocampal neural precursor cell lines with CRISPR/Cas9-mediated gene knockouts.
    Zocher S; Kempermann G
    STAR Protoc; 2021 Jun; 2(2):100472. PubMed ID: 33948565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation protocol for CRISPR/Cas9-mediated CD19 knockout GM24385 cells by flow cytometry and Sanger sequencing.
    Inwood SL; Tian L; Parratt K; Maragh S; Wang L
    Biotechniques; 2022 Jun; 72(6):279-286. PubMed ID: 35703314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient generation of locus-specific human CAR-T cells with CRISPR/cCas12a.
    Ling X; Chang L; Chen H; Liu T
    STAR Protoc; 2022 Jun; 3(2):101321. PubMed ID: 35496795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for Genome Editing to Produce Multiple Mutants in Wheat.
    Abe F; Ishida Y; Hisano H; Endo M; Komari T; Toki S; Sato K
    STAR Protoc; 2020 Sep; 1(2):100053. PubMed ID: 33111098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient and versatile CRISPR-Cas9 system for genetic manipulation of multi-drug resistant
    McConville TH; Giddins MJ; Uhlemann AC
    STAR Protoc; 2021 Mar; 2(1):100373. PubMed ID: 33733242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.